Jeil Pharmaceutical Co., Ltd. (271980)

Overview

Jeil Pharmaceutical Co., Ltd is an established entity in the pharmaceutical sector, primarily operating within South Korea. Founded in 1959, the company specializes in the development and supply of various pharmaceutical products. It has extended its reach to serve approximately 40 countries across different regions, including ASEAN, Central and South America, and Africa, affirming its international presence. Jeil Pharmaceutical is recognized for its contribution to multiple therapeutic areas, showcasing a robust portfolio that caters to diverse healthcare needs. With its headquarters in Seoul, South Korea, the company continues to innovate and lead in the pharmaceutical industry, emphasizing quality and efficacy in its offerings.

Products and Services

Jeil Pharmaceutical Co., Ltd provides an extensive range of pharmaceutical products, each tailored to meet specific healthcare requirements across various therapeutic domains. The company's product offerings include:

• Antibiotic: This category includes drugs designed to combat bacterial infections, addressing both common and specific antibiotic resistance challenges.
• Gastrointestinal: Products targeting diseases and disorders affecting the gastrointestinal tract, aiding in digestion and the overall health of the digestive system.
• Cardiovascular: Medications focused on treating conditions related to the heart and blood vessels, aiming to improve heart health and prevent related diseases.
• Neuropsychiatry: These drugs are intended for the treatment of disorders affecting the mind, such as depression, anxiety, schizophrenia, and bipolar disorder, contributing to mental well-being.
• Oncology: Offerings in this domain are dedicated to the diagnosis, treatment, and prevention of cancer, employing innovative approaches to combat this challenging disease.
• Endocrinology: Products focusing on hormonal imbalances and disorders, providing treatment options for conditions such as diabetes and thyroid diseases.
• Urology: Medications and therapies targeting the urinary tract and male reproductive organs, aiming to treat and manage conditions affecting these systems.
• Antiviral: These products are developed to counteract viral infections, offering treatments for diseases such as hepatitis and HIV.
• Antihistamine: Drugs in this category are designed to alleviate symptoms of allergic reactions, providing relief from conditions such as hay fever, urticaria, and common colds.

Furthermore, Jeil Pharmaceutical Co., Ltd is actively involved in exporting its products globally, reinforcing its commitment to improving health standards and accessibility to quality pharmaceuticals worldwide.